SuperGen to Present at Lazard Healthcare Conference on November 18, 2009

2009-11-11 12:14:04 -

SuperGen, Inc. (Nasdaq:SUPG), a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, today announced that James S.J. Manuso, Ph.D., President and Chief Executive Officer, will present at the Lazard Capital Markets 6th Annual Healthcare Conference on Wednesday, November 18, 2009 in New York.

SuperGen's presentation will begin at 9 a.m. ET. A live webcast of the presentation

will be available on the investor relations section of the Company's Web site at www.supergen.com : cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww .. .

The webcast will be archived for 90 days.



About SuperGen

SuperGen is a pharmaceutical company dedicated to the discovery and development of novel cancer therapeutics in epigenetic and cell signaling modulation. The Company develops products through biochemical and clinical proof of concept to partner for further development and commercialization. For more information about SuperGen, please visit www.supergen.com : cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww .. .



SuperGen, Inc.Timothy L. Enns, 925-560-2810Senior Vice
PresidentCorporate Communications & Business Development tenns@supergen.com : mailto:tenns@supergen.com Susanna

Chau, 925-560-2845ManagerInvestor Relations schau@supergen.com : mailto:schau@supergen.com